Skip to content
VisionOpenBlog

The Zimbabwean Government Turns Down ‘One-Sided’ US Health Aid Agreement Due to Data Fears

Medical funding image
The proposed US funding was intended for initiatives for HIV/Aids treatment and prevention, tuberculosis, and malaria.

Zimbabwe has rejected a substantial US healthcare agreement valued at 367 million US dollars (272 million pounds) over five years due to the United States' insistence on sensitive biological samples.

The decision came to light following a government memo dated December was leaked, which showed Head of State Emmerson Mnangagwa believed the arrangement was "skewed".

A government spokesperson later explained that the United States was demanding access to genetic material for scientific study and profit while was unwilling to guarantee the resulting advantages from future treatments.

"We are forced to start the difficult and regrettable task of ending our support in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.

The US Embassy noted the United States had donated over $1.9bn as health assistance to Zimbabwe over the last two decades.

A medical body in Zimbabwe has appealed for further talks to reach a deal suitable to both sides so the nation's vital HIV treatment initiative can be sustained.

Wider Implications

Zimbabwe's decision comes after a similar situation in neighbouring Kenya, where a high court suspended a similar health funding agreement after concerns were raised about the safety of citizens' medical information.

Since resuming the presidency last year, US President Donald Trump has slashed foreign aid and shut down the key foreign aid agency.

The agency had managed aid for the US government, but Trump argued its spending was "inefficient" and his government was seeking direct bilateral deals to boost transparency and accountability.

Based on statements, Sixteen nations in Africa have to date signed similar health pacts, constituting over $18.3bn of fresh investment.

Details of the Declined Deal

The funds for Zimbabwe was intended to supported "tackling HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".

"We are confident this partnership might have yielded immense advantages for Zimbabwean communities, especially the 1.2 million presently receiving HIV treatment via American-funded programmes," the Ambassador added.

However, government spokesperson Nick Mangwana said the proposed deal was "unequal".

"Zimbabwe was being asked to share its genetic material and health information for a long time, with no corresponding promise of access to any medical innovations – such as vaccines, diagnostics, or treatments – that could be developed from that shared data," his statement read.

"Put simply, our country would supply the basic resources for scientific discovery without any certainty that the end products would be available to our population should a future disease outbreak arise."

Sovereignty and International Frameworks

Mangwana further said that the US's withdrawal from the global health body and its pursuit of one-on-one health agreements were undermining structures already set up via the global health agency.

Mangwana gave as an example its Pandemic Benefit-Sharing framework created to deal with future global health emergencies.

"This framework is designed to guarantee that when a country contributes its information, the resulting advantages – including vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the capability to create them."

Zimbabwe's reservations regarding the US deal "must not be interpreted as anti-American sentiment," he added.

"We encourage continued dialogue with our US partners on how subsequent collaboration might be arranged in a manner that respects the sovereignty and interests of each country."

Health Experts Reaction

Medical experts stated it acknowledged the official position, but recommended that talks need to persist since a large portion of the country's Aids initiatives depended on international support.

"If technical issues exist, such as those involving information security or implementation frameworks, these can often be addressed through detailed discussion and mutually agreed protections," the group added.

The situation underscores the complex debate between receiving much-needed international aid and protecting a country's data in an increasingly interconnected world.

The writer

Heather Harris

Elara is a tech journalist and AI researcher with a passion for demystifying complex technologies and exploring their societal impacts.

VisionOpenBlog

Type to search articles.